184 related articles for article (PubMed ID: 36587172)
1. Development and Validation of a New Staging System for Esophageal Squamous Cell Carcinoma Patients Based on Combined Pathological TNM, Radiomics, and Proteomics.
Zheng SJ; Zheng CP; Zhai TT; Xu XE; Zheng YQ; Li ZM; Li EM; Liu W; Xu LY
Ann Surg Oncol; 2023 Apr; 30(4):2227-2241. PubMed ID: 36587172
[TBL] [Abstract][Full Text] [Related]
2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma.
Cao B; Mi K; Dai W; Liu T; Xie T; Li Q; Lang J; Han Y; Peng L; Wang Q
Chin J Cancer Res; 2022 Apr; 34(2):71-82. PubMed ID: 35685995
[TBL] [Abstract][Full Text] [Related]
5. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
6. A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
Yang Y; Yi Y; Wang Z; Li S; Zhang B; Sang Z; Zhang L; Cao Q; Li B
BMC Cancer; 2024 Apr; 24(1):460. PubMed ID: 38609892
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma.
Chu F; Liu Y; Liu Q; Li W; Jia Z; Wang C; Wang Z; Lu S; Li P; Zhang Y; Liao Y; Xu M; Yao X; Wang S; Liu C; Zhang H; Wang S; Yan X; Kamel IR; Sun H; Yang G; Zhang Y; Qu J
Eur Radiol; 2022 Sep; 32(9):5930-5942. PubMed ID: 35384460
[TBL] [Abstract][Full Text] [Related]
8. Increased prognostic value of clinical-reproductive model in Chinese female patients with esophageal squamous cell carcinoma.
Zhang DY; Ku JW; Zhao XK; Zhang HY; Song X; Wu HF; Fan ZM; Xu RH; You D; Wang R; Zhou RX; Wang LD
World J Gastroenterol; 2022 Apr; 28(13):1347-1361. PubMed ID: 35645543
[TBL] [Abstract][Full Text] [Related]
9. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
10. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
[TBL] [Abstract][Full Text] [Related]
12. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram.
Shao CY; Liu XL; Yao S; Li ZJ; Cong ZZ; Luo J; Dong GH; Yi J
Eur J Surg Oncol; 2021 Jun; 47(6):1473-1480. PubMed ID: 33349524
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
[TBL] [Abstract][Full Text] [Related]
15. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
Zhu Y; Yao W; Xu BC; Lei YY; Guo QK; Liu LZ; Li HJ; Xu M; Yan J; Chang DD; Feng ST; Zhu ZH
BMC Cancer; 2021 Oct; 21(1):1167. PubMed ID: 34717582
[TBL] [Abstract][Full Text] [Related]
16. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: A Multiomic Novel Staging System for Esophageal Squamous Cell Carcinoma Patients.
Zheng SJ; Li EM; Xu LY
Ann Surg Oncol; 2023 Apr; 30(4):2242-2243. PubMed ID: 36581725
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
19. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data.
Li ZM; Liu W; Chen XL; Wu WZ; Xu XE; Chu MY; Yu SX; Li EM; Huang HC; Xu LY
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102318. PubMed ID: 38471582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
